#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Neil Bander Email
Chief Scientific Officer . Convergent Therapeutics
How to contact Neil Bander
Join and see Neil's contact info for free!Current Roles
Employees:
18Revenue:
$1.4MAbout
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules like Prostate-Specific Membrane Antigen (PSMA) improves antitumor efficacy. By leveraging targeting agents with different bio-distributions, such as monoclonal antibodies and ligands, supra-additive therapeutic doses are delivered to tumor cells without additive toxicity to the patient.Convergent Therapeutics Address
1 Broadway 14th FloorCambridge, MA